US$ 28.03
aod9604 phase 2 trial results weight loss kg or percent The effects of a 14 day infusion of saline (control), hGH on Data from the Phase 2
Description
Unlike traditional HGH, AOD9604 does not significantly affect insulin-like growth factor 1 (IGF1) levels, meaning it was designed to stimulate fat breakdown without driving excess muscle growth or other unwanted hormonal changes

High doses may cause temporary headaches due to increased NAD+ turnover and mitochondrial activity
These injections are also beneficial for those looking to support energy levels, mental clarity, and skin health

Proc Natl Acad Sci USA 89 : 69836987 Oscarsson J et al

This kind of systemsbased approach is particularly important for patients who have plateaued on conventional diets or have complex conditions like prediabetes, fatty liver, or chronic fatigue

The lipotropic compounds in the injection help break down fat more efficiently, potentially aiding in weight loss efforts
